TY - JOUR A1 - Pippias, Maria A1 - Stel, Vianda S. A1 - Diez, José Maria Abad A1 - Afentakis, Nikolaos A1 - Herrero-Calvo, Jose Antonio A1 - Arias, Manuel A1 - Tomilina, Natalia A1 - Caamaño, Encarnación Bouzas A1 - Buturovic-Ponikvar, Jadranka A1 - Čala, Svjetlana A1 - Caskey, Fergus J. A1 - de la Nuez, Pablo Castro A1 - Cernevskis, Harijs A1 - Collart, Frederic A1 - de la Torre, Ramón Alonso A1 - de los Ángeles García Bazaga, Maria A1 - De Meester, Johan A1 - Díaz, Joan Manuel A1 - Djukanovic, Ljubica A1 - Alamar, Manuel Ferrer A1 - Finne, Patrik A1 - Garneata, Liliana A1 - Golan, Eliezer A1 - González Fernández, Raquel A1 - Gutiérrez Avila, Gonzalo A1 - Heaf, James A1 - Hoitsma, Andries A1 - Kantaria, Nino A1 - Kolesnyk, Mykola A1 - Kramar, Reinhard A1 - Kramer, Anneke A1 - Lassalle, Mathilde A1 - Leivestad, Torbjørn A1 - Lopot, Frantisek A1 - Macário, Fernando A1 - Magaz, Angela A1 - Martín-Escobar, Eduardo A1 - Metcalfe, Wendy A1 - Noordzij, Marlies A1 - Palsson, Runolfur A1 - Pechter, Ülle A1 - Prütz, Karl G. A1 - Ratkovic, Marina A1 - Resić, Halima A1 - Rutkowski, Boleslaw A1 - de Pablos, Carmen Santiuste A1 - Spustová, Viera A1 - Süleymanlar, Gültekin A1 - Van Stralen, Karlijn A1 - Thereska, Nestor A1 - Wanner, Christoph A1 - Jager, Kitty J. T1 - Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report T2 - Clinical Kidney Journal N2 - Background This article summarizes the 2012 European Renal Association—European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years). Methods Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented. Results In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3–60.0) which fell to 39.3% (95% CI: 38.7–39.9) in patients 65–74 years and 21.3% (95% CI: 20.8–21.9) in patients ≥75 years. KW - end-stage renal disease KW - incidence KW - prevalence KW - renal replacement therapy KW - survival Y1 - 2015 UR - https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/15005 UR - https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-150054 VL - 8 IS - 3 ER -